Michael D Menger

No ORCID on file · 38 papers in corpus · active 2005-2023

Study types

  • article 27
  • other 6
  • book-chapter 2
  • review 2
  • letter 1

Condition tags

  • mesh:D004715 30
  • endometriosis 27
article 2023
International journal of molecular sciences ·doi:10.3390/ijms241813858

Endometriosis is a common gynecological disease which is characterized by endometriotic lesions outside the uterine cavity. In this study, we investigated whether the presence of pre-existing endometriotic lesions promotes the development o…

article 2022
Nutrients ·doi:10.3390/nu14224940

Endometriosis represents an estrogen-dependent disorder with a complex pathophysiology. Phytochemicals are promising candidates for endometriosis therapy, because they simultaneously target different cellular processes involved in the patho…

article 2022
Scientific reports ·doi:10.1038/s41598-022-09577-z

Endometriosis develop from shed endometrial fragments via retrograde menstruation. This affects the survival, proliferation and vascularization of the tissue and its final ability to form endometriotic lesions. Within this study, uterine ti…

article 2021
Human Reproduction ·doi:10.1093/humrep/deab139

STUDY QUESTION: Is there a difference in the growth and vascularization between murine endometriotic lesions originating from menstrual or non-menstrual endometrial fragments? SUMMARY ANSWER: Endometriotic lesions developing from menstrual …

article 2021
British journal of pharmacology ·doi:10.1111/bph.15601

BACKGROUND AND PURPOSE: Limited evidence suggests that the sphingosine-1-phosphate/sphingosine kinase 1 (S1P/SPHK1) signalling pathway is involved in the pathogenesis of endometriosis. Therefore, we analyzed in this study whether the inhibi…

article 2020
British journal of pharmacology ·doi:10.1111/bph.15044

BACKGROUND AND PURPOSE: The development of endometriotic lesions is crucially dependent on the formation of new blood vessels. In the present study, we analysed whether this process is regulated by erythropoietin-producing hepatoma receptor…

article 2019
Journal of ethnopharmacology ·doi:10.1016/j.jep.2019.111918
other 2019
PloS one ·doi:10.1371/journal.pone.0226835

Accumulating evidence indicates that there is an interaction between the gut microbiota and endometriotic lesions. The new formation of these lesions is associated with stem cell recruitment, angiogenesis and inflammation, which may affect …

article 2018
Human reproduction update ·doi:10.1093/humupd/dmy001

BACKGROUND: Vascularization is a major hallmark in the pathogenesis of endometriosis. An increasing number of studies suggests that multiple mechanisms contribute to the vascularization of endometriotic lesions, including angiogenesis, vasc…

other 2018
The American journal of pathology ·doi:10.1016/j.ajpath.2017.10.013

The incorporation of endothelial progenitor cells (EPCs) into newly developing blood vessels contributes to the vascularization of endometriotic lesions. We analyzed whether cyclooxygenase (COX)-2 signaling regulates this vasculogenic proce…

letter 2018
Human reproduction update ·doi:10.1093/humupd/dmy024
article 2017
British journal of pharmacology ·doi:10.1111/bph.13874

BACKGROUND AND PURPOSE: Telmisartan suppresses the development of endometriotic lesions. However, the drug also up-regulates the expression of COX-2, which has been suggested to promote the progression of endometriosis. Accordingly, in the …

book-chapter 2017
·doi:10.1007/978-3-319-42202-2_26
article 2017
Angiogenesis ·doi:10.1007/s10456-017-9580-7
other 2017
European journal of medicinal chemistry ·doi:10.1016/j.ejmech.2016.11.004

Current endocrine therapeutics for the estrogen-dependent disease endometriosis often lead to considerable side-effects as they act by reducing estrogen action systemically. A more recent approach takes advantage of the fact that the weak e…

article 2016
The American journal of pathology ·doi:10.1016/j.ajpath.2016.04.004
article 2016
PloS one ·doi:10.1371/journal.pone.0152302

BACKGROUND: The development and long-term survival of endometriotic lesions is crucially dependent on an adequate vascularization. Hyaluronic acid (HA) through its receptor CD44 has been described to be involved in the process of angiogenes…

article 2016

Size and spatial orientation of uterine tissue transplants on the peritoneum crucially determine the growth and cyst formation of endometriosis-like lesions in mice

article 2016
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2016.02.036
article 2015

Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes

article 2014
Human Reproduction ·doi:10.1093/humrep/deu035

STUDY QUESTION: Is telmisartan effective in the treatment of endometriosis? SUMMARY ANSWER: Combined blockade of angiotensin II type 1 receptor (AT1R) and activation of peroxisome proliferator-activated receptor (PPAR)-γ by telmisartan inhi…

article 2013
Disease models & mechanisms ·doi:10.1242/dmm.013664

In endometriosis research, endometriosis-like lesions are usually induced in rodents by transplantation of isolated endometrial tissue fragments to ectopic sites. In the present study, we investigated whether this approach is affected by th…

article 2013
Medical hypotheses ·doi:10.1016/j.mehy.2013.02.016
article 2013
Human Reproduction ·doi:10.1093/humrep/det031

STUDY QUESTION: Does the phytochemical compound resveratrol inhibit vascularization of endometriotic lesions? SUMMARY ANSWER: Resveratrol suppresses the development of new microvessels in endometriotic lesions by inhibiting endothelial cell…

other 2013
Fertility and sterility ·doi:10.1016/j.fertnstert.2013.07.1967

OBJECTIVE: To study the effect of combretastatin A4 phosphate (CA4P) on the vascularization of endometriotic lesions. DESIGN: Intravital microscopic, histologic, and immunohistochemical study. SETTING: University institute. ANIMAL(S): BA…